{"changes":[{"companyHref":"/c/adela-io","date":"2026-09-25","documentUrl":null,"domain":"adela.io","fact":"latest round","name":"Adela, Inc.","new":{"amountUsd":5000000,"date":"2026-04-10","lead":null,"type":null},"old":{"amountUsd":5000000,"date":"2026-04-10","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-05-07","slug":"adela-io","status":"attributed","url":"https://whoraisedwhat.com/c/adela-io"}],"country":"US","description":"Adela Bio develops blood-based tests that speed cancer diagnosis and improve disease management. It serves cancer patients across the care continuum, from early screening to post-surgery monitoring and immunotherapy response. Its tissue-free detection platform works across multiple cancer types from a single blood draw.","domain":"adela.io","employees":null,"founded":2020,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotechnology","investors":[],"lat":37.566522,"lng":-122.274401,"location":"FOSTER CITY, CA","name":"Adela, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":5000000,"currency":"USD","date":"2026-04-10","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-07","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"adela-io","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-05-07","status":"attributed","url":null},{"fact":"existence","publisher":"adela.io","retrievedAt":"2026-05-07","status":"self-reported","url":"https://adela.io"},{"fact":"description","publisher":"adela.io","retrievedAt":"2026-05-07","status":"self-reported","url":"https://adela.io"}],"stage":null,"techStack":[],"totalRaisedUsd":60000000,"updatedAt":"2026-05-07"}